The incidence of nosocomial infections from Gram-positive pathogens has been increasing
in the last two decades, alongside the development of antibiotic resistance in many bacteria …

Linezolid (Zyvox®), the first available oxazolidinone antibacterial agent, has good activity
against Gram-positive pathogens, including multidrug-resistant organisms such as …

Background: New antibiotics efficacious in infections caused by resistant Gram-positive
microorganisms and with acceptable costs for national health systems per unit of …

Gram-positive bacteria have emerged as major causes of colonization and serious infection
within the nosocomial and increasingly also within the community setting. These infections …

Multidrug-resistant pathogens have become increasingly common in contemporary
healthcare. Specific to Gram-positive pathogens, methicillin-resistant Staphylococcus …

Gram-positive pathogens are a significant cause of morbidity and mortality in both
community and health care settings. Glycopeptides have traditionally been the antibiotics of …

Multi-drug resistant Gram-positive cocci have emerged as significant pathogens of
community-and hospital-acquired infections. Several antimicrobial agents that can be used …

The aim of this study was to perform a comparative cost-effectiveness analysis of linezolid vs
teicoplanin (iv, switching to oral/im respectively) in Spain. A decision tree model was used …

The purpose of this report is to examine the comparative clinical effectiveness of linezolid,
vancomycin and daptomycin for Methicillin-resistant Staphylococcus aureus (MRSA) …

Multi-antibiotic resistant Gram-positive cocci, which include Staphylococcus aureus, the
coagulase-negative staphylococcal group, Enterococcus faecalis and Enterococcus …